Verdence Capital Advisors LLC grew its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 4.3% in the 3rd quarter, ...

Needham & Company LLC restated their hold rating on shares of Boston Scientific (NYSE:BSX – Free Report) in a report released ...

Singh Chadha covers the Healthcare sector, focusing on stocks such as Johnson & Johnson, Medtronic, and Boston Scientific ... It develops and commercializes senza spinal cord stimulation system, an ...

BOSTON — We’ve all seen it – that characteristic full ... They discovered that the C-LTMR neurons connect to a specific group of neurons in the spinal cord, which then relay the information to a brain ...

Boston Scientific has proven itself to be ... and increased adoption of the S-ICD and advances in spinal cord stimulation for chronic pain. The 2020 dip in profitability due to covid ...

The webcast will be held on November 26, 2024, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver who will discuss highlights from Q3 2024 and provide a business update. To join the ...

Spinal cord and dorsal root ganglion stimulation are established, safe treatments for chronic pain, but they carry a high explantation risk over a long-term period. The long-term explantation ...

Summary of Mount Sinai's New York BCI Symposium, by Synchron and Precision Neuroscience. Market Trends and forecast for brain ...

Company to provide update on significant milestones and near-term plans, including its recent successful financing and agreements with Ottobock and CEAEINDHOVEN, the Netherlands, Nov. 12, 2024 (GLOBE ...